![Darren Shafren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Darren Shafren
Oprichter bij ImmVirX Pty Ltd.
Actieve functies van Darren Shafren
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The University of Newcastle | Corporate Officer/Principal | - | - |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Oprichter | - | - |
Loopbaan van Darren Shafren
Eerdere bekende functies van Darren Shafren
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VIRALYTICS LTD. | Directeur/Bestuurslid | - | 25-10-2009 |
Hoofd Techniek/Wetenschap/O&O | 25-10-2009 | 01-07-2019 | |
Directeur van Onderzoek - Eigen Vermogen | 25-10-2009 | 25-10-2009 |
Statistieken
Internationaal
Australië | 4 |
Operationeel
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Director of Research - Equity | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Viralytics Pty Ltd.
![]() Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Commercial Services |
- Beurs
- Insiders
- Darren Shafren
- Ervaring